{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:12:23Z","timestamp":1786389143055,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118822","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T19:37:53Z","timestamp":1606851473000},"page":"118822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Cilostazol preconditioning alleviates cyclophosphamide-induced cardiotoxicity in male rats: Mechanistic insights into SIRT1 signaling pathway"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8383-8383","authenticated-orcid":false,"given":"Rania A.","family":"Elrashidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118822_bb0005","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","article-title":"Cardiotoxicity associated with high-dose cyclophosphamide therapy","volume":"141","author":"Gottdiener","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118822_bb0015","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1093\/eurheartj\/ehv290","article-title":"Protective effects of sirtuins in cardiovascular diseases: from bench to bedside","volume":"36","author":"Winnik","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2020.118822_bb0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/ars.2017.7178","article-title":"SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection","volume":"28","author":"D\u2019Onofrio","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118822_bb0025","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1073\/pnas.1934713100","article-title":"Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice","volume":"100","author":"Cheng","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118822_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4602715","article-title":"SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice","volume":"2017","author":"Ma","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118822_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nm.4284","article-title":"Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel","volume":"23","author":"Vikram","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0040","doi-asserted-by":"crossref","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","article-title":"Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy","volume":"298","author":"Sulaiman","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2020.118822_bb0045","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-012-0925-5","article-title":"SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes","volume":"69","author":"Becatti","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2020.118822_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbrc.2013.07.042","article-title":"Resveratrol protects cardiomyocytes from oxidative stress through SIRT1 and mitochondrial biogenesis signaling pathways","volume":"438","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118822_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6746907","article-title":"Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway","volume":"2019","author":"Li","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118822_bb0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2013.07.007","article-title":"SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury","volume":"65","author":"Yang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0065","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/VHRM.S3160","article-title":"Safety and efficacy of cilostazol in the management of intermittent claudication","volume":"4","author":"Chi","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2020.118822_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2015.07.016","article-title":"Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice","volume":"89","author":"Koh","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.biopha.2017.07.143","article-title":"Cilostazol protects mice against myocardium ischemic\/reperfusion injury by activating a PPARgamma\/JAK2\/STAT3 pathway","volume":"94","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118822_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yjmcc.2018.08.017","article-title":"Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice","volume":"123","author":"Reddy","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2020.118822_bb0085","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/ATVBAHA.108.164368","article-title":"Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells","volume":"28","author":"Ota","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.118822_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/1440-1681.13004","article-title":"Beneficial effects of cilostazol on liver injury induced by common bile duct ligation in rats: role of SIRT1 signaling pathway","volume":"45","author":"Kabil","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2020.118822_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-005-2735-7","article-title":"Cytoprotective role of DL-alpha-lipoic acid in cyclophosphamide induced myocardial toxicity","volume":"276","author":"Mythili","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118822_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0253-7613.106434","article-title":"Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study","volume":"45","author":"Viswanatha Swamy","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118822_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/ijmm.2017.3014","article-title":"(\u2212)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia\/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions","volume":"40","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2020.118822_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0102-86502014001700004","article-title":"Effects of ischemic preconditioning and cilostazol on muscle ischemia-reperfusion injury in rats","volume":"29","author":"Frias Neto","year":"2014","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.lfs.2020.118822_bb0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1074248411431581","article-title":"Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy","volume":"17","author":"Elrashidy","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.118822_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/JMAU.JMAU_53_18","article-title":"Potential toxic effect of bisphenol a on the cardiac muscle of adult rat and the possible protective effect of omega-3: a histological and immunohistochemical study","volume":"7","author":"Bahey","year":"2019","journal-title":"J. Microsc. Ultrastruct."},{"key":"10.1016\/j.lfs.2020.118822_bb0125","first-page":"454","article-title":"Immunohistochemical and stereologic analysis of NF-kappaB activation in chronic periodontitis","volume":"4","author":"Arabaci","year":"2010","journal-title":"Eur. J. Dent."},{"key":"10.1016\/j.lfs.2020.118822_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","article-title":"Redox regulation of FoxO transcription factors","volume":"6","author":"Klotz","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2020.118822_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-kappaB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.lfs.2020.118822_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131394","article-title":"Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention","volume":"10","author":"Nishikawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118822_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13104-017-2726-2","article-title":"Role of metabolites of cyclophosphamide in cardiotoxicity","volume":"10","author":"Kurauchi","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.lfs.2020.118822_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4161\/oxim.3.5.13107","article-title":"Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues","volume":"3","author":"Asiri","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118822_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/2156587218757649","article-title":"Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats","volume":"23","author":"Omole","year":"2018","journal-title":"J. Evid. Based Integr. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0160","doi-asserted-by":"crossref","first-page":"e0127813","DOI":"10.1371\/journal.pone.0127813","article-title":"Blueberry anthocyanins-enriched extracts attenuate cyclophosphamide-induced cardiac injury","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118822_bb0165","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.110.958033","article-title":"Silent information regulator 1 protects the heart from ischemia\/reperfusion","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118822_bb0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/cvr\/cvy033","article-title":"Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury","volume":"114","author":"Wang","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118822_bb0175","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118822_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/MCB.26.1.28-38.2006","article-title":"Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage","volume":"26","author":"Solomon","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118822_bb0185","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1021\/jm050522v","article-title":"Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1","volume":"48","author":"Napper","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118822_bb0190","doi-asserted-by":"crossref","first-page":"E2772","DOI":"10.1073\/pnas.1303628110","article-title":"Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism","volume":"110","author":"Gertz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118822_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086977","article-title":"Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice","volume":"9","author":"Shalwala","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118822_bb0200","doi-asserted-by":"crossref","first-page":"H486","DOI":"10.1152\/ajpheart.00437.2004","article-title":"Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure","volume":"288","author":"Pillai","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2020.118822_bb0205","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41467-019-09014-2","article-title":"DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2020.118822_bb0210","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/MCB.00121-09","article-title":"SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1","volume":"29","author":"Rajamohan","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118822_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","article-title":"Negative control of p53 by Sir2alpha promotes cell survival under stress","volume":"107","author":"Luo","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118822_bb0220","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.RES.0000147557.75257.ff","article-title":"Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes","volume":"95","author":"Alcendor","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.118822_bb0225","first-page":"4965171","article-title":"The role of antioxidants in ameliorating cyclophosphamide-induced cardiotoxicity","author":"Ayza","year":"2020","journal-title":"Oxidative Med. Cell. Longev"},{"key":"10.1016\/j.lfs.2020.118822_bb0230","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1532\/HSF98.20101126","article-title":"Cilostazol, a type III phosphodiesterase inhibitor, reduces ischemia\/reperfusion-induced spinal cord injury","volume":"14","author":"Sahin","year":"2011","journal-title":"Heart Surg. Forum"},{"key":"10.1016\/j.lfs.2020.118822_bb0235","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/02713683.2018.1542734","article-title":"Cilostazol attenuates retinal oxidative stress and inflammation in a streptozotocin-induced diabetic animal model","volume":"44","author":"Yeh","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.lfs.2020.118822_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.107.164186","article-title":"Forkhead transcription factors and cardiovascular biology","volume":"102","author":"Papanicolaou","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.118822_bb0245","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2020.118822_bb0250","doi-asserted-by":"crossref","first-page":"e46364","DOI":"10.1371\/journal.pone.0046364","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118822_bb0255","first-page":"5032","article-title":"Protective effects of resveratrol on osteoporosis via activation of the SIRT1-NF-kappaB signaling pathway in rats","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2020.118822_bb0260","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.yjmcc.2011.09.013","article-title":"Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice","volume":"51","author":"Kawashima","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2020.118822_bb0265","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:22:22Z","timestamp":1758986542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520315757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":53,"alternative-id":["S0024320520315757"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118822","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol preconditioning alleviates cyclophosphamide-induced cardiotoxicity in male rats: Mechanistic insights into SIRT1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118822"}}